Allergy medication while breastfeeding is a common concern for mothers managing hay fever, allergic rhinitis, eczema, or urticaria. The reassuring news is that several allergy medicines are considered compatible with breastfeeding when used at the lowest effective dose. NHS guidance and the UK Drugs in Lactation Advisory Service (UKDILAS) generally support the view that the benefits of breastfeeding outweigh the small risks posed by most commonly used allergy treatments. However, safety profiles vary considerably between medicines, and some options — particularly older, sedating antihistamines — are best avoided. This guide outlines which medications are recommended, which to avoid, and when to seek professional advice.

Is it safe to take allergy medication while breastfeeding?

Many allergy medications are considered compatible with breastfeeding at the lowest effective dose; NHS and UKDILAS guidance supports their use when benefits outweigh the small risks, though extra caution is needed for premature or newborn infants.

Many breastfeeding mothers experience allergic conditions such as hay fever, allergic rhinitis, eczema, or urticaria and may wonder whether it is safe to take allergy medication whilst continuing to feed their baby. The good news is that several allergy medicines are considered compatible with breastfeeding, provided they are used appropriately and at the lowest effective dose.

The general principle, as supported by NHS guidance and the UK Drugs in Lactation Advisory Service (UKDILAS), is that the benefits of breastfeeding typically outweigh the small risks associated with most commonly used allergy medications. However, not all antihistamines and allergy treatments carry the same safety profile, and some are not recommended as first-line options during breastfeeding and should generally be avoided unless advised by a healthcare professional.

Extra caution is warranted for premature infants, those who are unwell, or in the early neonatal period (particularly the first four weeks), when infants are less able to metabolise and clear medicines. Individual circumstances — including the age and health of the infant, the dose required, and the duration of treatment — all influence the overall risk-benefit assessment.

Mothers should always seek personalised advice from a GP, pharmacist, or specialist before starting or continuing any medication whilst breastfeeding. Resources such as the UKDILAS Medicines Advice service and the Breastfeeding Network's Drugs in Breastmilk helpline can also provide evidence-based guidance. Any suspected side effects in the mother or infant should be reported via the MHRA Yellow Card Scheme.

Experiencing these side effects? Our pharmacists can help you navigate them →

Which antihistamines are recommended by NHS guidance?

Loratadine is the first-line antihistamine recommended during breastfeeding, with cetirizine as an acceptable alternative; both are non-sedating and transfer into breast milk in very low amounts.

NHS guidance and UKDILAS generally recommend non-sedating (second-generation) antihistamines as the preferred choice for managing allergic symptoms during breastfeeding. These are considered safer primarily because they carry a much lower risk of causing sedation in the mother or the infant compared with older, first-generation antihistamines.

The following non-sedating antihistamines are most commonly recommended:

• Loratadine — widely regarded as the first-line antihistamine during breastfeeding; it has a well-established safety record, is highly protein-bound, and transfers into breast milk in very low amounts

• Cetirizine — another second-generation antihistamine considered acceptable during breastfeeding; loratadine is generally preferred as the first choice, but cetirizine is a reasonable alternative

• Desloratadine and levocetirizine — also considered acceptable alternatives per NHS and BNF guidance

• Fexofenadine — generally considered low risk by UKDILAS and the BNF; however, some manufacturers' Summaries of Product Characteristics (SmPCs) advise caution due to limited lactation data, so use should be discussed with a pharmacist or GP

For nasal symptoms specifically, intranasal corticosteroid sprays — including beclometasone, budesonide, and fluticasone — are considered safe options, as systemic absorption is minimal and they act locally within the nasal passages. These are often preferred for persistent allergic rhinitis as they address the underlying inflammation rather than simply masking symptoms.

For allergic conjunctivitis, sodium cromoglicate or ketotifen eye drops are considered safe options. When using any eye drops, applying gentle pressure over the inner corner of the eye (punctal occlusion) for one to two minutes after instillation can help minimise systemic absorption.

Topical treatments — including emollients or mild topical corticosteroids for eczema — are also generally considered safe, as systemic absorption remains low. Always check the product's patient information leaflet and confirm suitability with a pharmacist.

Medications to avoid when breastfeeding

Sedating antihistamines (chlorphenamine, promethazine, diphenhydramine) and oral decongestants (pseudoephedrine) should generally be avoided during breastfeeding due to risks of infant sedation and reduced milk supply.

Whilst several allergy medications are considered safe, others carry a higher risk profile and are not recommended as first-line options during breastfeeding. First-generation (sedating) antihistamines — such as chlorphenamine (Piriton), promethazine, and diphenhydramine — should generally be avoided. These older antihistamines may cause sedation, irritability, or feeding difficulties in the infant. There is also a theoretical concern regarding respiratory depression in very young, premature, or medically fragile infants.

If a sedating antihistamine is considered necessary on specialist advice — for example, for short-term use at the lowest effective dose — the infant should be monitored for signs of excessive sleepiness or poor feeding. Importantly, mothers who have taken any sedating medicine should not share a bed with their baby, as this increases the risk of accidental suffocation.

Promethazine warrants particular caution: whilst its use by breastfeeding mothers is not formally contraindicated, it is generally avoided due to the risk of infant sedation. It is contraindicated for direct use in children under two years of age, which underlines the need for caution when a breastfeeding mother takes it. Despite being available over the counter, sedating antihistamines should not be assumed safe simply because they do not require a prescription.

Other medications to approach with caution include:

• Oral decongestants such as pseudoephedrine and phenylephrine — pseudoephedrine in particular has evidence of reducing milk supply and may cause irritability in the infant; systemic decongestants should be avoided where possible. Topical nasal decongestants (e.g., xylometazoline or oxymetazoline nasal sprays) are a safer short-term alternative, as systemic absorption is minimal, though they should not be used for more than a few days at a time

• Oral corticosteroids — short courses of prednisolone (typically up to 40 mg/day) are generally considered compatible with breastfeeding; prolonged or high-dose therapy requires specialist guidance and may warrant monitoring of the infant

• Combination cold and allergy products — many over-the-counter products contain multiple active ingredients, including decongestants or sedating antihistamines, making them unsuitable during breastfeeding

Mothers should always read labels carefully and consult a pharmacist before purchasing any over-the-counter allergy remedy.

Still have questions? Message our pharmacists for free →

How allergy medicines pass into breast milk

Medicines transfer into breast milk via passive diffusion; factors including molecular weight, protein binding, and lipid solubility determine the extent of transfer, with most recommended antihistamines achieving a relative infant dose well below 10%.

Understanding how medications transfer into breast milk can help contextualise the level of risk involved. When a breastfeeding mother takes any medication, it enters her bloodstream and may subsequently pass into breast milk through a process of passive diffusion. The extent to which this occurs depends on several pharmacological factors.

Key factors influencing drug transfer into breast milk include:

• Molecular weight — smaller molecules pass more easily into milk

• Lipid solubility — highly fat-soluble drugs concentrate more readily in breast milk

• Protein binding — drugs that are highly protein-bound in the bloodstream are less available to transfer into milk

• Half-life — drugs with longer half-lives remain in the body (and potentially in milk) for longer periods

• pH and ionisation — weakly basic drugs may concentrate slightly in the more acidic environment of breast milk

Non-sedating antihistamines such as loratadine and cetirizine have favourable pharmacokinetic profiles: they are highly protein-bound and transfer into breast milk in very low amounts. Typical relative infant doses (RIDs) for these agents are well below 2%, meaning the amount reaching the infant is negligible.

The relative infant dose (RID) is a useful screening tool used by clinicians to assess safety — a RID of less than 10% is generally considered a pragmatic threshold for acceptability. Most recommended antihistamines fall well within this range. However, RID is a guide rather than an absolute safety guarantee; clinical judgement remains essential, particularly for newborn or preterm infants who may be less able to metabolise medicines efficiently.

The timing of peak drug levels in milk varies with the half-life and formulation of each medicine, which is relevant when considering strategies to minimise infant exposure.

Managing allergy symptoms safely during breastfeeding

A combined approach of allergen avoidance, nasal saline rinses, and the safest available medication at the lowest effective dose is recommended; poorly controlled conditions such as asthma pose greater risk than the medicines used to treat them.

Beyond medication, there are several practical strategies that can help breastfeeding mothers manage allergy symptoms whilst minimising any potential risk to their infant. A combined approach — using non-pharmacological measures alongside the safest available medications at the lowest effective dose — is often the most effective.

Non-pharmacological strategies include:

• Allergen avoidance — identifying and reducing exposure to known triggers such as pollen, pet dander, dust mites, or certain foods

• Nasal saline rinses — isotonic saline sprays or nasal irrigation can help relieve nasal congestion and reduce the need for medication

• Applying a small amount of petroleum jelly around the nostrils to help trap pollen before it is inhaled

• Showering, washing hair, and changing clothes after returning indoors from outdoor exposure

• Keeping windows closed during peak pollen times

• Air purifiers with HEPA filters — useful for reducing indoor allergen load, particularly during high pollen seasons

• Wearing wraparound sunglasses outdoors to reduce eye exposure to pollen

• Punctal occlusion when using eye drops — pressing gently on the inner corner of the eye for one to two minutes after instillation reduces systemic absorption

When medication is necessary, taking antihistamines immediately after a breastfeed may help reduce infant exposure for shorter-acting agents, as drug levels in the milk are likely to be lower by the time of the next feed. However, this strategy has limited benefit for once-daily, long half-life medicines such as loratadine, where milk levels remain relatively stable throughout the day.

For mothers with persistent or severe allergic conditions such as asthma or chronic urticaria, it is important not to under-treat symptoms. Poorly controlled asthma, for example, poses a greater risk to both mother and infant than the medications used to manage it. In line with NICE guidance (NG80) and BTS/SIGN recommendations, inhaled corticosteroids (including beclometasone, budesonide, and fluticasone) and bronchodilators (including salbutamol, formoterol, and salmeterol) are all considered compatible with breastfeeding and should be continued as prescribed.

When to seek advice from a GP or pharmacist

Seek immediate medical advice if anaphylaxis is suspected (call 999), or consult a GP or pharmacist before starting any new allergy medication, particularly if the infant shows unusual symptoms such as excessive sleepiness or poor feeding.

Whilst many allergy medications can be safely self-managed with guidance from a community pharmacist, there are circumstances in which it is important to seek formal medical advice. Breastfeeding mothers should contact their GP or pharmacist before starting any new allergy medication, particularly if they are unsure about its safety profile or if their symptoms are new, worsening, or not responding to standard treatments.

Seek prompt medical advice if:

• Allergy symptoms are severe, persistent, or significantly affecting daily functioning

• There are signs of a serious allergic reaction — including difficulty breathing, throat or tongue swelling, hoarseness, wheeze, dizziness, or collapse — call 999 immediately if anaphylaxis is suspected

• The infant shows any unusual symptoms after the mother takes medication, such as excessive sleepiness, poor feeding, irritability, or skin changes

• The mother requires a medication not listed as safe during breastfeeding, or needs a prolonged course of treatment

• There is uncertainty about whether a product contains ingredients that may be harmful

For urgent out-of-hours queries, NHS 111 can provide guidance when a GP is not immediately available.

Pharmacists are an excellent first point of contact for straightforward queries and can advise on suitable over-the-counter options. For more complex cases, GPs may refer to an allergy specialist or consult resources such as the Breastfeeding Network's Drugs in Breastmilk helpline or UKDILAS, which provide specialist lactation pharmacology advice.

Any suspected adverse effects in the mother or infant that may be related to a medicine should be reported via the MHRA Yellow Card Scheme (available at yellowcard.mhra.gov.uk). Healthcare professionals and patients can both submit reports.

It is always better to seek guidance than to either avoid necessary treatment or take a medication that may not be appropriate. With the right support, most breastfeeding mothers can manage their allergy symptoms safely and effectively without compromising their ability to breastfeed.

Frequently Asked Questions